|
ATP2B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.577300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.721700E-02 |
| Normal-vs-Stage2 |
1.783850E-01 |
| Normal-vs-Stage3 |
2.551800E-01 |
| Normal-vs-Stage4 |
8.596100E-02 |
| Stage1-vs-Stage2 |
8.255000E-01 |
| Stage1-vs-Stage3 |
6.996200E-01 |
| Stage1-vs-Stage4 |
1.600570E-01 |
| Stage2-vs-Stage3 |
8.403200E-01 |
| Stage2-vs-Stage4 |
1.913590E-01 |
| Stage3-vs-Stage4 |
1.915400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.272290E-02 |
| Normal-vs-AfricanAmerican |
8.403900E-03 |
| Normal-vs-Asian |
3.765400E-01 |
| Caucasian-vs-AfricanAmerican |
2.220800E-01 |
| Caucasian-vs-Asian |
3.823000E-01 |
| AfricanAmerican-vs-Asian |
7.156800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.636300E-03 |
| Normal-vs-Female |
8.582700E-03 |
| Male-vs-Female |
2.216000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.014800E-01 |
| Normal-vs-Extreme_Weight |
3.060000E-02 |
| Normal-vs-Obese |
2.488100E-02 |
| Normal-vs-Extreme_Obese |
6.574800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.476800E-01 |
| Normal_Weight-vs-Obese |
1.551370E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.812000E-01 |
| Extreme_Weight-vs-Obese |
4.130600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.552800E-01 |
| Obese-vs-Extreme_Obese |
2.393200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.064900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.008200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.383800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.933200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.026200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.189570E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.078120E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.864100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.475900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.012400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.766240E-04 |
| Normal-VS-Type2 PRCC |
8.412100E-02 |
| Normal-VS-KIRP CIMP |
2.022300E-04 |
| Normal-VS-Unclassified PRCC |
2.445700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.81190000003717E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.770800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.511200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.233090E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.324400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.39170000000599E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.256200E-01 |
| Normal-vs-N1 |
1.816420E-02 |
| Normal-vs-N2 |
2.001000E-01 |
| N0-vs-N1 |
2.376500E-02 |
| N0-vs-N2 |
2.739900E-02 |
| N1-vs-N2 |
9.737600E-01 |
|
|
